Methadone: A Flicker Of Light In The Dark
Methadone: A Flicker Of Light In The Dark
Methadone: A Flicker Of Light In The Dark
Would you like to react to this message? Create an account in a few clicks or log in to continue.

Methadone: A Flicker Of Light In The Dark

To provide a better understanding of the very important role methadone plays in the treatment of addiction.
 
HomeHome  PortalPortal  GalleryGallery  Latest imagesLatest images  RegisterRegister  Log inLog in  

 

 PROPOXYPHENE (darvocet, darvon etc) BEING TAKEN OFF THE MARKET DUE TO CARDIAC TOXICITY

Go down 
AuthorMessage
lilgirllost
Admin
lilgirllost


Female
Number of posts : 863
Age : 51
Location : live in Louisiana but attend MMT clinic in Tx
Job/hobbies : COUPONING & GEOCACHING are my favorite past times but I also love reading and spending time with my husband and kids
Humor : I don't have a sense of humor.............
Registration date : 2009-05-25

PROPOXYPHENE (darvocet, darvon etc) BEING TAKEN OFF THE MARKET DUE TO CARDIAC TOXICITY Empty
PostSubject: PROPOXYPHENE (darvocet, darvon etc) BEING TAKEN OFF THE MARKET DUE TO CARDIAC TOXICITY   PROPOXYPHENE (darvocet, darvon etc) BEING TAKEN OFF THE MARKET DUE TO CARDIAC TOXICITY EmptySun Nov 21, 2010 6:11 pm

Propoxyphene: Withdrawal - Risk of Cardiac Toxicity
November 19, 2010

Sold as Darvon, Darvocet, and generics


ISSUE: FDA notified healthcare professionals that Xanodyne Pharmaceuticals has agreed to withdraw propoxyphene, an opioid pain reliever used to treat mild to moderate pain, from the U.S. market at the request of the FDA, due to new data showing that the drug can cause serious toxicity to the heart, even when used at therapeutic doses. FDA concluded that the safety risks of propoxyphene outweigh its benefits for pain relief at recommended doses. FDA requested that the generic manufacturers of propoxyphene-containing products remove their products as well.

BACKGROUND: FDA’s recommendation is based on all available data including data from a new study that evaluated the effects that increasing doses of propoxyphene have on the heart (see Data Summary in Drug Safety Communication). The results of the new study showed that when propoxyphene was taken at therapeutic doses, there were significant changes to the electrical activity of the heart: prolonged PR interval, widened QRS complex and prolonged QT interval. These changes can increase the risk for serious abnormal heart rhythms.

RECOMMENDATION: FDA recommends that healthcare professionals stop prescribing and dispensing propoxyphene-containing products to patients, contact patients currently taking propoxyphene-containing products and ask them to discontinue the drug, inform patients of the risks associated with propoxyphene, and discuss alternative pain management strategies. Patients were advised to dispose of unused propoxyphene in household trash by following the recommendations outlined in the Federal Drug Disposal Guidelines.

Original link

http://www.drugs.com/fda/propoxyphene-risk-cardiac-toxicity-12855.html
Back to top Go down
 
PROPOXYPHENE (darvocet, darvon etc) BEING TAKEN OFF THE MARKET DUE TO CARDIAC TOXICITY
Back to top 
Page 1 of 1

Permissions in this forum:You cannot reply to topics in this forum
Methadone: A Flicker Of Light In The Dark :: Forum News :: Announcements, Events and Breaking News-
Jump to: